Cargando…
Label-Free Raman Spectromicroscopy Unravels the Relationship between MGMT Methylation and Intracellular Lipid Accumulation in Glioblastoma
[Image: see text] Temozolomide (TMZ) is considered a first line chemotherapy drug for glioblastoma (GBM). Unfortunately, the GBM without methylation of O(6)-methylguanine-DNA methyltransferase (MGMT), accounting for about 70% of all GBM, shows an inherent resistance to TMZ treatment. Aberrant accumu...
Autores principales: | Wang, Nana, Wang, Jiejun, Wang, Pu, Ji, Nan, Yue, Shuhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413324/ https://www.ncbi.nlm.nih.gov/pubmed/37417930 http://dx.doi.org/10.1021/acs.analchem.3c00967 |
Ejemplares similares
-
Label‐Free Nanoimaging of Neuromelanin in the Brain by Soft X‐ray Spectromicroscopy
por: Brooks, Jake, et al.
Publicado: (2020) -
Association between MGMT Enhancer Methylation and MGMT Promoter Methylation, MGMT Protein Expression, and Overall Survival in Glioblastoma
por: Zappe, Katja, et al.
Publicado: (2023) -
Cathode lens spectromicroscopy: methodology and applications
por: Menteş, T O, et al.
Publicado: (2014) -
MGMT promoter methylation in Peruvian patients with glioblastoma
por: Belmar-Lopez, Carolina, et al.
Publicado: (2018) -
Characterization of Biomaterials by Soft X-Ray Spectromicroscopy
por: Leung, Bonnie O., et al.
Publicado: (2010)